CN106668492A - 回族中药芪根胃癌消丸及其制备方法 - Google Patents
回族中药芪根胃癌消丸及其制备方法 Download PDFInfo
- Publication number
- CN106668492A CN106668492A CN201510749366.3A CN201510749366A CN106668492A CN 106668492 A CN106668492 A CN 106668492A CN 201510749366 A CN201510749366 A CN 201510749366A CN 106668492 A CN106668492 A CN 106668492A
- Authority
- CN
- China
- Prior art keywords
- pill
- cancer
- preparation
- extracted
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010017758 gastric cancer Diseases 0.000 title claims abstract description 33
- 208000005718 Stomach Neoplasms Diseases 0.000 title claims abstract description 32
- 201000011549 stomach cancer Diseases 0.000 title claims abstract description 32
- 239000006187 pill Substances 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000009636 Huang Qi Substances 0.000 title claims abstract description 12
- 238000011282 treatment Methods 0.000 title abstract description 16
- 244000113428 Sonchus oleraceus Species 0.000 title abstract 3
- 235000006745 Sonchus oleraceus Nutrition 0.000 title abstract 3
- 239000003814 drug Substances 0.000 claims abstract description 39
- 241000756943 Codonopsis Species 0.000 claims abstract description 19
- 238000000605 extraction Methods 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims abstract description 13
- 241000411851 herbal medicine Species 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 230000000694 effects Effects 0.000 claims description 32
- 239000008187 granular material Substances 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 9
- 238000011085 pressure filtration Methods 0.000 claims description 9
- -1 pressure filtration Substances 0.000 claims description 9
- 239000008399 tap water Substances 0.000 claims description 9
- 235000020679 tap water Nutrition 0.000 claims description 9
- 240000002234 Allium sativum Species 0.000 claims description 7
- 235000004611 garlic Nutrition 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 235000013599 spices Nutrition 0.000 claims description 6
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 claims description 5
- 235000021286 stilbenes Nutrition 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 235000019640 taste Nutrition 0.000 claims description 4
- 229910000831 Steel Inorganic materials 0.000 claims description 3
- 229920001617 Vinyon Polymers 0.000 claims description 3
- 230000003321 amplification Effects 0.000 claims description 3
- 230000004087 circulation Effects 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000000428 dust Substances 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000010959 steel Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 241000208340 Araliaceae Species 0.000 claims 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims 1
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 1
- 235000008434 ginseng Nutrition 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 29
- 230000000144 pharmacologic effect Effects 0.000 abstract description 5
- 208000002699 Digestive System Neoplasms Diseases 0.000 abstract description 3
- 206010009944 Colon cancer Diseases 0.000 abstract description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 abstract description 2
- 208000024348 heart neoplasm Diseases 0.000 abstract description 2
- 244000241463 Cullen corylifolium Species 0.000 abstract 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 abstract 1
- 241000037831 Polygonatum sibiricum Species 0.000 abstract 1
- 206010043515 Throat cancer Diseases 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 201000004101 esophageal cancer Diseases 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 21
- 201000011510 cancer Diseases 0.000 description 20
- 230000007812 deficiency Effects 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000006907 apoptotic process Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 206010003694 Atrophy Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000032023 Signs and Symptoms Diseases 0.000 description 3
- 208000007107 Stomach Ulcer Diseases 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000037444 atrophy Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 210000002249 digestive system Anatomy 0.000 description 3
- 201000005917 gastric ulcer Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010019375 Helicobacter infections Diseases 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- BJBUTJQYZDYRMJ-UHFFFAOYSA-N Kaempferol 3,7-dimethyl ether Chemical compound C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C=C1 BJBUTJQYZDYRMJ-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 208000024558 digestive system cancer Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 201000005619 esophageal carcinoma Diseases 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 201000010231 gastrointestinal system cancer Diseases 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001662 opsonic effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 101000633503 Homo sapiens Nuclear receptor subfamily 2 group E member 1 Proteins 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010062038 Lip neoplasm Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 102100029534 Nuclear receptor subfamily 2 group E member 1 Human genes 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 241001468611 Polygonatum cyrtonema Species 0.000 description 1
- 241000037826 Polygonatum kingianum Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010043966 Tongue neoplasm malignant stage unspecified Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- RBFQJDQYXXHULB-UHFFFAOYSA-N arsane Chemical compound [AsH3] RBFQJDQYXXHULB-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 208000010749 gastric carcinoma Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000011587 gastric lymphoma Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000006721 lip cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000001589 lymphoproliferative effect Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 238000002638 palliative care Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 201000011598 pylorus cancer Diseases 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明详述了回族中药“芪根胃癌消丸”的配方及其制备方法,该药是一种治疗晚期胃癌特别是因为各种原因无法进行手术的晚期胃癌的绿色高科技中草药。它是以黄芪、党参、苦菜根、五加皮、补骨脂、黄精等中草药按一定比例混合加水煎熬、提取、浓缩、制丸而成的中药丸剂,主治胃癌,兼治咽喉癌、食管癌、喷门癌、大肠癌等消化系统癌症,本发明的特点是药味少,剂量适中,所选的药味大都是被现代医学药理实验证明是能够治疗癌症的。
Description
技术领域
本发明涉及的回族中药芪根胃癌消丸是一种治疗晚期胃癌特别是因为各种原因无法进行手术的晚期胃癌的绿色高科技中草药。本发明还涉及该药的制备方法,属于中医药类。
背景技术
据《2014年中国肿瘤登记年报》数据显示,按照中国人平均74岁的寿命计算,中国人一生患恶性肿瘤的几率是22%,平均每分钟有6人被诊断为恶性肿瘤,肿瘤在中国已经成为一种常见疾病。目前中国的癌症患者约为700多万人,且每年以100多万人的速度在增加。而全世界呢?
据统计,在我国近800万的癌症患者中,有31.27%为消化系统癌患者,其中胃癌患者占消化系统癌患者的41.83%,几近一半。
中国是胃癌发病率最高的国家之一,全球每年新发胃癌患者100余万,中国就占了42%,死亡人数中国占到了35%,中国胃癌的发病率和死亡率均是世界平均水平的2倍多!这其中的遗传因素、免疫因素、幽门螺杆菌感染因素都不在话下,最让人揪心的则是环境和饮食因素……
胃癌的早期症状不明显,通常从胃癌发病到发现肿瘤需要两年左右的时间,因此往往被忽视,而一旦到了不可忍受,十有八九已到了晚期。
目前治胃癌最好的方法是手术,术后还要进行化疗,而化疗不但副作用大,患者痛苦难以忍受,而且成功率也很低,绝大多数患者化疗后的生存期连一年都不到——当然这也与无良医生的过度治疗有关。而另一方面,一些人虽然被检测出是胃癌,但是由于各种原因无法进行手术,只能姑息治疗,期待奇迹的降临……
胃癌是目前较难治愈的疾病,但难治并不代表没法可治,除上述西医治疗方法外,中医也有很多有效的治疗方法。中医以整体观念根据患者的全身特点辨证论治,可以适用于各型各期癌症。中医药治疗癌症的优势在于有利于稳定病情,毒副作用轻微、症状改善较明显,使病情发展减慢、肿瘤缩小或带瘤较长期生存,患者易于接受和费用比较低廉。目前西医也认为中医药可以作为癌症的辅助治疗,有助于减少放、化疗的毒性,改善癌症相关症状,提高生存质量,延长生存期。但存在的问题是中医的药方统一性较差,治疗主要凭的是经验。从已有的治癌验方、偏方看,所选中草药药材中总是有一些——多数是超过半数以上的——药物都是没有被现代医学药理实验证明是有治癌功能和作用的“辨证施治”的“配伍”药,本发明人认为挺不合适;而偏方呢,偏方治病靠的是试验,往往耽搁治病的时间。
发明内容
本发明的目的,就是针对中国癌症患者就诊难以及中医病方统一性差、可重复性差、高级别的循证医学理论和证据相对缺乏,因而治癌主要是凭经验等不足之情况,提出一种新的配药方法以及制备方法,提供一种从预防开始,降低胃癌的发病率,从癌变开始减缓其进展速度,从肿瘤开始诱导其萎缩凋亡的绿色高科技中草药。具体地说,本发明一是特别适用于治疗癌前较大胃溃疡以防其癌变,二是可治疗胃癌初期的特大胃溃疡,以防其继续恶化,三是可诱导已经成瘤的癌肿萎缩凋亡,以很低的花费,从根本上改善身体机能,从而恢复健康。它的最大优势在于能最大限度地诱导癌细胞自我凋亡与分化,促使癌肿逐步萎缩。在具体的配方中,还配合辨证施治,根据胃癌的成因因饮食因素使营养素失去平衡致免疫功能低下,因幽门螺旋杆菌感染引起胃部正常细胞被损害、凋亡,胃炎、消化道溃疡、淋巴增生性胃淋巴瘤“乘虚而入”邪毒压正,因病久瘀血内结邪毒夹裹瘀血乘虚流窜经络客于脏腑久而成积致胃癌转移等基本病理病机的特点,运用健脾益肾扶正祛邪攻补兼施之法,以纠正正气内虚、邪凝毒聚和脏腑阴阳失调功能降低之不足,调整并提高机体的免疫功能。同时根据患者的具体情况,分别采用不同的配方,或舒肝和胃、降逆止痛,或解毒祛瘀,清热养阴,或温中散寒,健脾和胃,或大补气血,健脾补肾……以达到攻补兼施、补泻并用、整体抑瘤的目的,从而提高胃癌治疗的整体疗效和远期疗效,为胃癌患者提供一种已经被现代医学药理实验证明是有治癌功能和作用的绿色高科技中草药配方以及配制方法,以很低或是较低的花费,从根本上改善身体机能,控制病情的恶化并使病情逐渐好转,最终恢复身体健康。由此也给患者一个根据个人病情、经济状况、个人意愿来综合考虑选择不同治疗方法或几种方法合用特别是中西医相结合综合治疗应用的余地,以期获得最佳疗效,轻松提高生存率——特别是5年以上生存率。
本发明所提出的技术方案是:
一、所述的治疗胃癌的回族中药芪根胃癌消丸及其制备方法,是由下列重量配比原料制成的:
黄 芪9g、 苦菜根30g、 香茶菜根30g、党参9g、
五加皮9g、 补骨脂9g、 黄 精9g、 黄连3g、
紫皮蒜3瓣、 蜂蜜50g、
此方为一日一剂煎服的基本方。在实际应用时,还可根据患者的体质及病症情况,增加1-3味中医“天人合一、辩证论治”理论的“辨证配伍”药。
考虑到用该基本方煎服汤药量大、味道欠佳,患者很难饮用,故必须应用特殊工艺进行制备。
二、将上述各原料制成本发明所述的中药丸剂的制备方法为:
A、 提取物的制备
(1)、提取
a、第一次提取:将上述中草药的重量除党参、黄连、紫皮蒜、蜂蜜以外,全部放大10倍,清水清洗后,置于BT-2 不锈钢提取釜中,加7-9 倍自来水后,加热至100℃恒温提取1小时左右,分离提取液,加压过滤,滤液备用。
b、第二次提取:往提取釜内加入5-7 倍量的自来水,加热至100℃恒温提取半小时左右,分离提取液,加压过滤,滤液备用。
c、第三次提取:往提取釜内加入3-5倍量的自来水,加热至100℃恒温提取20分钟左右,分离提取液,加压过滤,滤液备用。
(2)、浓缩
将三次的提取液合并,置于B-500 型三效真空高能蒸发浓缩器内,减压( 负200mmHg),加热至80℃,浓缩至相对密度1.10 ~ 1.20,备用。
(3)、制粉
先将紫皮蒜3瓣放大10倍切片烤干或阴干,再将党参9g、黄连3g各放大10倍,一同粉碎为末,过80目筛,备用。
(4)、配料
在30 万级洁净车间内,将药粉与前述浓缩物以及蜂蜜50g一起置混合机中充分混合,搅拌均匀。
(5)、 烘干、粉碎
将混合均匀的药料置于烘箱中60-70℃烘烤4-5小时,然后粉碎,过100 目筛。
(6)、造粒
将混合均匀的药料置入造粒机中造粒。
(7)、整粒
将制好的颗粒进行整粒,过35目筛。
(8)、干燥
将整好的颗粒置入热循环干燥箱内,80℃下通风干燥至水分< 8%。
(9) 制丸
将干燥混合所得药物置中药制丸机中制丸,丸粒以4mm以下最佳。
B、包装
将丸剂装入聚乙烯塑料小袋中,每袋8-10g,再将装好的小袋装盒、装箱、灭菌( 采用60Co 辐照,辐照剂量为8kGy)。
C、 入库
将辐照过的成品按先进先出的原则进行入库。
本发明常规服用方法:上述丸剂每日三次,每次1袋,空腹( 服后半小时不可大量喝水,以免冲淡药液)。服药期间勿食用辛辣等对胃肠道刺激性较大的食物。本药三个月为一疗程,一般服用二至三个疗程,最多服用四个疗程。
本发明各原料的作用:
黄芪,黄芪性甘,微温。归脾、肺经。补脾肺气,升阳举陷,益卫固表,利尿,托毒生肌。黄芪为豆科植物蒙古黄芪膜荚黄芪的干燥根。含氨基酸、粘液质、糖类、苦味素、胆碱甜菜碱叶酸、熊竹素,β-谷甾醇(、黄芪多糖等。凡癌症患者因脾肺气虚所致面色白光白,倦怠无力,纳少便溏,吐血便血,咳喘气短,痰多稀白,少气懒言,乏力自汗,心悸失眠,气虚发热,浮肿尿少等均可用之。黄芪能增强网状内皮系统的吞噬功能,对干扰素系统有促进作用,对癌患者淋巴细胞功能有完全性免疫恢复作用,对癌前病变胃溃疡有极好疗效。
苦菜根,性味功效:味苦,性平。宣肺,散寒,祛痰排脓。临床应用:适用于肺癌、咽喉部肿瘤等。此外,还适于外感咳、咳痰不爽、咽喉肿痛、胸痛、胸闷腹胀、支气管炎、肺脓疡、胸膜炎、抗溃疡等。
香茶菜根,性味甘,苦,性凉。功能主治:清热解毒,祛瘀止痛。主毒蛇咬伤,疮疖肿毒,筋骨酸痛,跌打损伤,烫火伤,健脾,活血,治胃炎,肝炎初起,感冒发热,经闭,乳腺炎,关节痛。日本从香茶菜中提出之延命草素有抗肿瘤作用。
党参,功效与作用:“补中益气,生津,健脾,和脾胃,除烦渴。” 中医认为党参性平味甘,归脾、肺经,有补中益气,健脾益肺之功效,可用于脾肺虚弱、气短心悸、食少便溏、虚喘咳嗽、内热消渴等症。而最新科学研究发现,党参中含有的多种营养物质,对人的身体免疫力,血管,以及其他器官都有帮助。党参能够促进人体内血液循环,同时还有造血再生,促进红细胞生长的作用。从而有效帮助人们增强身体免疫力,提高身体素质。党参对人的消化系统有很好的调理作用。不仅当人的消化系统已经出现病变的时候,可以使用党参来治疗疾病,比如当人的胃酸分泌过多的时候可以通过服用党参煎剂来调理,而且,平常的时候就可以事先服用一些党参,来预防消化系统的疾病,以及促进消化系统的健康。由于党参对人的免疫系统也有一定的调理作用,因此食用一些党参制品,可以使人身体的免疫能力上升,降低人体疾病的发生率。除外,党参还有调节心脑血管系统功能,促进心脑血管系统健康的作用;特别是具有造血、调节血压、降低血压等作用。
五加皮,性味归经:辛、苦,温。人肝、肾经。功效:祛风湿,壮筋骨,活血去瘀。治风寒湿痹,筋骨挛急,腰痛,阳痿,脚弱,小儿行迟,水肿,脚气,疮疽肿毒,跌打劳伤。作用:本品性温,能温通血脉,有活血祛瘀之功,用于外伤骨折或跌打损伤,有活血祛瘀、通凝化滞之效,又有滋补作用,以促进早愈。补肾益智,抗炎,镇静、镇痛,抗疲劳,增强巨噬细胞诱生干扰素,可增强T细胞、NK细胞、K细胞、巨噬细胞杀伤肿瘤细胞的效应,升高白细胞,能明显促进骨髓系祖细胞集落的形成,对化疗放疗引起的骨髓抑制有明显的保护和白细胞升高作用,解毒,还具有抗肿瘤作用。
补骨脂,味辛;苦;性温,肾;心包;脾;胃;肺经。功能主治:补肾助阳;纳气平喘;温脾止泻。主肾阳不足;下元虚冷;腰膝冷痛;阳痿遗精;尿频;遗尿;肾不纳气;虚喘不止;脾肾两虚;大便久泻;抗肿瘤作用。
黄精,为百合科植物滇黄精、黄精或多花黄精的干燥根茎。性味:甘;平。 归经:脾经;肺经;肾经。功效:养阴润肺;补脾益气,滋肾填精。有养阴润肺;补脾益气,滋肾填精的功效。常配甘麦大枣汤,芍药柔肝养心,治小儿多动症,神经官能症。配黄芪,牡蛎,黄连等益气养阴,泻火泻热,治甲状腺功能亢进。配山楂,枸杞,女贞子,丹参治代谢中和症。并防治动脉硬化,延缓衰老。主治:阴虚劳嗽;肺燥咳嗽;脾虚乏力;食少口干;消渴;肾亏腰膝酸软;阳痿遗精;耳鸣目暗;须发早白;体虚赢瘦;风癞癣疾。作用:黄精具有降血压,降血糖,降血脂,防止动脉粥样硬化,延缓衰老和抗菌等作用,黄精多糖具有免疫激活作用。用于阴虚肺燥,干咳少痰,及肺肾阴虚的劳嗽久咳等。用于脾胃虚弱。既补脾阴,又益脾气,用于肾虚精亏得头晕,腰膝酸软,须发早白及消渴等。
黄连,性味功效: 味苦、性寒。清热燥湿,泻火解毒。临床应用: 适用于多种胂瘤,如肝、胆肿瘤,舌癌,唇癌,食管癌,胃癌,膀胱癌等。此外,还适用于高热神昏、吐血、衄血、疔疮肿毒,湿疮瘙痒、急性结膜炎、口疮、细菌性痢疾、急性肠胄炎、热盛心烦、痞满、消渴、烧伤等症。
蜂蜜,蜂蜜的功效与作用:1.心血管患者的佳品,蜂蜜能改善血液的成分,促进心脑和血管功能,因此经常服用于心血管病人很有好处;2.保护肝脏,蜂蜜对肝脏有保护作用,能促使肝细胞再生,对脂肪肝的形成有一定的抑制作用;3.增强抵抗力,食用蜂蜜能迅速补充体力,消除疲劳,增强对疾病的抵抗力;4.杀菌,蜂蜜还有杀菌的作用,经常食用蜜糖,不仅对牙齿无妨碍,还能在口腔内起到杀菌消毒的作用,蜂蜜能治疗中度的皮肤伤害,特别是烫伤,将蜂蜜当做皮肤伤口敷料时,细菌无法生长;5.促进睡眠,失眠的人在每天睡觉前口服1汤匙蜜糖(加入1杯温开水内),可以帮助尽快进入梦乡;6.促进胃肠蠕动,蜂蜜对胃肠功能有调节作用,可使胃酸分泌正常。动物实验证实,蜂蜜有增强肠蠕动的作用,可显著缩短排便时间。
本发明的效果:
主治:胃癌,特别是由于各种原因无法进行胃癌手术的晚期胃癌,以很低的花费,从根本上改善身体机能,控制肿瘤继续疯长并使其逐渐缩小最终消失,从而恢复身体健康。
兼治:咽喉癌、食管癌、喷门癌、幽门癌、大肠癌等消化系统癌症。
本方的特点在于:
1、药味多,剂量适中,不浪费。
2、所选的药味大都是被现代医学药理实验证明是能够治癌的,而已有的治癌验方,偏方中则总是有半数以上的药物都是没有被现代医学药理实验证明是有治癌功能和作用的。
3、针对病灶,箭箭穿心,即所选药味都特别特别钟情于射中靶心,药到病除。而不是只要治癌,就一哄而上,结果是“龙”多反而不好治水。
4、尽最大可能“中性化”,即所选药味总体上保持“中性”,不寒不燥,不热不凉。这样就能使患者在整个服药的周期内少吃苦头、少受煎熬。而真要是出现“上火”或者“下泄”的情况,则完全可以针对具体个体的具体情况,临时辩证地添加一点“止泄”、“降火”的药物具体解决。而不是一开始就想象着患者可能就会上吐或者下泻,而把一些不必要的药物添加进方子,使患者在很长很长的服药期间都一直服用,最终造成不良后果。
具体实施方式:将黄芪9g、苦菜根30g、香茶菜根30g、五加皮9g、补骨脂9g、黄精11g各放大10倍,清水清洗后,置于BT-2 不锈钢提取釜中,加7-9倍自来水后,加热至100℃恒温提取1小时左右,分离提取液,加压过滤,滤液备用。第二次提取:往提取釜内加入5-7倍量的自来水,加热至100℃恒温提取半小时左右,分离提取液,加压过滤,滤液备用。第三次提取:往提取釜内加入3-5倍量的自来水,加热至100℃恒温提取20分钟左右,分离提取液,加压过滤,滤液备用。浓缩:将三次的提取液合并,置于B-500 型三效真空高能蒸发浓缩器内,减压( 负200mmHg),加热至80℃,浓缩至相对密度1.10 ~ 1.20,备用。制粉:先将紫皮蒜3瓣放大10倍切片烤干或阴干,再将党参9g、黄连3g各放大10倍,一同粉碎为末,过80目筛,备用。配料:在30 万级洁净车间内,将药粉与前述浓缩物以及50g蜂蜜一起置混合机中充分混合,搅拌均匀。烘干、粉碎:将混合均匀的药料置于烘箱中60-70℃烘烤4-5小时,然后粉碎,过100 目筛。造粒:将混合均匀的药料置入造粒机中造粒。整粒:将制好的颗粒进行整粒,过35目筛。干燥:将整好的颗粒置入热循环干燥箱内,80℃下通风干燥至水分< 8%。 制丸:将干燥混合所得药物置中药制丸机中制丸,丸粒以4mm以下最佳。包装:将制好的丸剂装入聚乙烯塑料小袋中,每袋8-10g,再将装好的小袋装盒、装箱、灭菌( 采用60Co 辐照,辐照剂量为8kGy)。最后,将辐照过的成品按先进先出的原则进行入库。
本发明除了制成丸粒外,也可以少掉制丸的工艺(序),直接制备成颗粒(粒剂)。
Claims (3)
1.回族中药“芪根胃癌消丸”及其制备方法,其特征在于它是由下列重量配比的原料制成的:
黄 芪9g、 苦菜根30g、 香茶菜根30g、党参9g、
五加皮9g、 补骨脂9g、 黄
精9g、 黄连0.5g、
紫皮蒜3瓣、 蜂蜜30g、
此方为一日一剂煎服的基本方,在实际应用时,还可根据患者的体质及病症情况,增加1-3味“辨证配伍”药。
2.根据权利要求1 所述的回族中药“芪根胃癌消丸”的重量配比,其特征在于包括下述制备步骤:
A、 提取物的制备
(1)、提取
a、第一次提取:将上述中草药的重量除党参、黄连、紫皮蒜、蜂蜜以外,全部放大10倍,清水清洗后,置于BT-2
不锈钢提取釜中,加7-9 倍自来水后,加热至100℃恒温提取1小时左右,分离提取液,加压过滤,滤液备用;
b、第二次提取:往提取釜内加入5-7 倍量的自来水,加热至100℃恒温提取半小时左右,分离提取液,加压过滤,滤液备用;
c、第三次提取:往提取釜内加入3-5倍量的自来水,加热至100℃恒温提取20分钟左右,分离提取液,加压过滤,滤液备用;
(2)、浓缩
将三次的提取液合并,置于B-500 型三效真空高能蒸发浓缩器内,减压( 负200mmHg),加热至80℃,浓缩至相对密度1.10 ~ 1.20,备用;
(3)、制粉
先将紫皮蒜3瓣放大10倍切片烤干或阴干,再将党参9g、黄连3g各放大10倍,一同粉碎为末,过80目筛,备用;
(4)、配料
在30 万级洁净车间内,将药粉与前述浓缩物以及蜂蜜50g一起置混合机中充分混合,搅拌均匀;
(5)、 烘干、粉碎
将混合均匀的药料置于烘箱中60-70℃烘烤4-5小时,然后粉碎,过100 目筛;
(6)、造粒
将混合均匀的药料置入造粒机中造粒;
(7)、整粒
将制好的颗粒进行整粒,过35目筛;
(8)、干燥
将整好的颗粒置入热循环干燥箱内,80℃下通风干燥至水分< 8%;
(9) 制丸
将干燥混合所得药物置中药制丸机中制丸,丸粒以4mm以下最佳;
B、包装
将丸剂装入聚乙烯塑料小袋中,每袋8-10g,再将装好的小袋装盒、装箱、灭菌( 采用60Co 辐照,辐照剂量为8kGy);
C、 入库
将辐照过的成品按先进先出的原则进行入库。
3. 权利要求1 所述的回族中药“参木胃癌散丸”及其制备方法,其特征在于它还可以根据权利要求2的制备步骤直接制作成颗粒(粒剂)。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510749366.3A CN106668492A (zh) | 2015-11-08 | 2015-11-08 | 回族中药芪根胃癌消丸及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510749366.3A CN106668492A (zh) | 2015-11-08 | 2015-11-08 | 回族中药芪根胃癌消丸及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106668492A true CN106668492A (zh) | 2017-05-17 |
Family
ID=58858432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510749366.3A Withdrawn CN106668492A (zh) | 2015-11-08 | 2015-11-08 | 回族中药芪根胃癌消丸及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106668492A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108186470A (zh) * | 2018-03-15 | 2018-06-22 | 扬州工业职业技术学院 | 一种复方中药提取物及其作为美白防晒剂的应用 |
-
2015
- 2015-11-08 CN CN201510749366.3A patent/CN106668492A/zh not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108186470A (zh) * | 2018-03-15 | 2018-06-22 | 扬州工业职业技术学院 | 一种复方中药提取物及其作为美白防晒剂的应用 |
| CN108186470B (zh) * | 2018-03-15 | 2020-05-26 | 扬州工业职业技术学院 | 一种复方中药提取物及其作为美白防晒剂的应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106668409A (zh) | 回族中药舌草食管抗癌口服液及其制备方法 | |
| CN106668495A (zh) | 回族中药芪根胃癌消口服液及其制备方法 | |
| CN106668494A (zh) | 回族中药芪根胃癌消颗粒及其制备方法 | |
| CN106668496A (zh) | 回族中药芪根胃癌消片及其制备方法 | |
| CN106668704A (zh) | 回族中药参木胃癌散颗粒及其制备方法 | |
| CN106668716A (zh) | 回族中药术子胃癌康口服液及其制备方法 | |
| CN106668724A (zh) | 回族中药术子胃癌康颗粒及其制备方法 | |
| CN106668499A (zh) | 回族中药附札胃癌消片及其制备方法 | |
| CN106668498A (zh) | 回族中药附札胃癌消丸及其制备方法 | |
| CN106668740A (zh) | 回族中药术子胃癌康片及其制备方法 | |
| CN106668533A (zh) | 回族中药慈菇胃癌消丸及其制备方法 | |
| CN106668416A (zh) | 回族中药三子胃癌康丸及其制备方法 | |
| CN106668729A (zh) | 回族中药术子胃癌康丸及其制备方法 | |
| CN106668406A (zh) | 回族中药三子胃癌康口服液及其制备方法 | |
| CN106668539A (zh) | 回族中药慈菇胃癌消颗粒及其制备方法 | |
| CN106668580A (zh) | 回族中药莲蝎胃癌消丸及其制备方法 | |
| CN106668413A (zh) | 回族中药三子胃癌康片及其制备方法 | |
| CN106668733A (zh) | 回族中药参木胃癌散丸及其制备方法 | |
| CN106668522A (zh) | 回族中药慈菇胃癌消片及其制备方法 | |
| CN106668582A (zh) | 回族中药莲蝎胃癌消颗粒及其制备方法 | |
| CN106668421A (zh) | 回族中药舌草食管抗癌颗粒及其制备方法 | |
| CN106668532A (zh) | 回族中药慈菇胃癌消口服液及其制备方法 | |
| CN106668410A (zh) | 回族中药三子胃癌康颗粒及其制备方法 | |
| CN106668500A (zh) | 回族中药附札胃癌消颗粒及其制备方法 | |
| CN106668497A (zh) | 回族中药附札胃癌消口服液及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170517 |
|
| WW01 | Invention patent application withdrawn after publication |